Literature DB >> 34150936

A Simple and Robust Protocol for in vitro Differentiation of Mouse Non-pathogenic T Helper 17 Cells from CD4+ T Cells.

Siwen Kang1, Ruohan Wu1, Ruoning Wang1.   

Abstract

Functional and mechanistic studies of CD4+ T cell lineages rely on robust methods of in vitro T cell polarization. Here, we report an optimized protocol for in vitro differentiation of a mouse non-pathogenic T helper 17 (TH17) cell lineage. Most of the previously established protocols require irradiated splenocytes as artificial antigen presenting cells (APC) for TCR activation. The protocol described here employs plate-bound antibodies and a TH17-polarizing cytokine cocktail to activate and differentiate naïve CD4+ T (Tnai) cells, reflecting a simple and robust protocol for in vitro TH17n differentiation. Using T cells that are genetically engineered with an IL-17 reporter, this protocol may enable the rapid production of a pure population of IL17-expressing CD4+ T cells for system biology studies and high-throughput functional screening.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  TH17 ; FACS; IL-17; Plate-bound; T cell polarization

Year:  2021        PMID: 34150936      PMCID: PMC8187118          DOI: 10.21769/BioProtoc.4029

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  17 in total

1.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

Review 2.  Unexpected targets and triggers of autoimmunity.

Authors:  Youjin Lee; Mary Collins; Vijay K Kuchroo
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

Review 3.  Flow Cytometry: An Overview.

Authors:  Katherine M McKinnon
Journal:  Curr Protoc Immunol       Date:  2018-02-21

Review 4.  Th17 cytokines in mucosal immunity and inflammation.

Authors:  Lokesh Guglani; Shabaana A Khader
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

Review 5.  IL-17 signaling in host defense against Candida albicans.

Authors:  Sarah L Gaffen; Nydiaris Hernández-Santos; Alanna C Peterson
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

7.  Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells.

Authors:  Amit Awasthi; Lorena Riol-Blanco; Anneli Jäger; Thomas Korn; Caroline Pot; George Galileos; Estelle Bettelli; Vijay K Kuchroo; Mohamed Oukka
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

8.  De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function.

Authors:  Ruohan Wu; Xuyong Chen; Siwen Kang; Tingting Wang; Jn Rashida Gnanaprakasam; Yufeng Yao; Lingling Liu; Gaofeng Fan; Mark R Burns; Ruoning Wang
Journal:  Sci Adv       Date:  2020-12-16       Impact factor: 14.136

9.  Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.

Authors:  Marc Veldhoen; Keiji Hirota; Jillian Christensen; Anne O'Garra; Brigitta Stockinger
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307

10.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.